The average length of stay in French hospitals for hyperplasia of the prostate is projected to decline from 3.1 days in 2024 to 2.4 days by 2028. This represents an overall decrease as projected, continuing the trend from prior data. In 2023, the average stay was approximately 3.3 days. The year-on-year variations show a decline of roughly 6.5% from 2024 to 2025 and a continuous decrease with a similar trend. The five-year Compound Annual Growth Rate (CAGR) indicates an average annual decrease of about 5.3% over this period.
Future trends to watch for:
- Advancements in medical technology and minimally invasive procedures which could further reduce hospitalization durations.
- Healthcare policy changes and efficiency improvements which may impact stays.
- Patient preferences and increasing outpatient treatment popularity affecting hospital admissions and length of stays.
